These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9606106)
21. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis. Lynnhtun K; Renthawa J; Varikatt W Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699 [TBL] [Abstract][Full Text] [Related]
23. Flow-cytometric quantification in human gliomas of alpha satellite DNA sequences specific for chromosome 7 using fluorescence in situ hybridization. Kwak T; Nishizaki T; Ito H; Kimura Y; Murakami T; Sasaki K Cytometry; 1994 Sep; 17(1):26-32. PubMed ID: 8001457 [TBL] [Abstract][Full Text] [Related]
24. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748 [TBL] [Abstract][Full Text] [Related]
25. Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms. Stålhammar G; Farrajota P; Olsson A; Silva C; Hartman J; Elmberger G Ann Diagn Pathol; 2015 Aug; 19(4):203-10. PubMed ID: 25921313 [TBL] [Abstract][Full Text] [Related]
26. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma. Tawfik OW; Kimler BF; Davis M; Donahue JK; Persons DL; Fan F; Hagemeister S; Thomas P; Connor C; Jewell W; Fabian CJ Histopathology; 2006 Feb; 48(3):258-67. PubMed ID: 16430472 [TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Chen Z; Huang X; Ye J; Pan P; Cao Q; Yang B; Li Z; Su M; Huang C; Gu J Cancer; 2010 Apr; 116(8):1953-63. PubMed ID: 20186824 [TBL] [Abstract][Full Text] [Related]
28. In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression. Miracco C; De Santi MM; Luzi P; Lalinga AV; Laurini L; De Nisi MC; Angeloni G; Brogi M; Cardone C; Carducci A; Arcuri F; Tosi P; Rubino G; Pirtoli L Int J Oncol; 2003 Dec; 23(6):1529-35. PubMed ID: 14612923 [TBL] [Abstract][Full Text] [Related]
29. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III. Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054 [TBL] [Abstract][Full Text] [Related]
30. Quantification of inter- and intra-nuclear variation of fluorescence in situ hybridization signals. Nederlof PM; van der Flier S; Raap AK; Tanke HJ Cytometry; 1992; 13(8):831-8. PubMed ID: 1459000 [TBL] [Abstract][Full Text] [Related]
31. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618 [TBL] [Abstract][Full Text] [Related]
32. A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating brain sections and primary neuronal cultures. Grabinski TM; Kneynsberg A; Manfredsson FP; Kanaan NM PLoS One; 2015; 10(3):e0120120. PubMed ID: 25794171 [TBL] [Abstract][Full Text] [Related]
33. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247 [TBL] [Abstract][Full Text] [Related]
34. Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation. Pruneri G; Mazzarol G; Fabris S; Del Curto B; Bertolini F; Neri A; Viale G Mod Pathol; 2003 Sep; 16(9):886-92. PubMed ID: 13679452 [TBL] [Abstract][Full Text] [Related]
35. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors. Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650 [TBL] [Abstract][Full Text] [Related]
36. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Zlatian OM; Comănescu MV; Roşu AF; Roşu L; Cruce M; Găman AE; Călina CD; Sfredel V Rom J Morphol Embryol; 2015; 56(1):175-81. PubMed ID: 25826503 [TBL] [Abstract][Full Text] [Related]
37. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization. Nwanze J; Cohen C; Schmitt AC; Siddiqui MT Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661 [TBL] [Abstract][Full Text] [Related]
38. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors. Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708 [TBL] [Abstract][Full Text] [Related]
39. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization. Wang W; Tang Y; Li J; Jiang L; Jiang Y; Su X Cancer Cytopathol; 2015 Feb; 123(2):117-22. PubMed ID: 25529354 [TBL] [Abstract][Full Text] [Related]
40. Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study. Hanna WM; Barnes PJ; Chang MC; Gilks CB; Magliocco AM; Rees H; Quenneville L; Robertson SJ; SenGupta SK; Nofech-Mozes S J Clin Oncol; 2014 Dec; 32(35):3967-73. PubMed ID: 25385731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]